Abstract: Disclosed are a class of compounds having a highly selective inhibition of ROS1, and the use thereof in the preparation of drugs for treating diseases related to abnormal ROS1 kinase expression. Specifically disclosed are compounds represented by formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a crystal of a carcinogenic fused kinase inhibitor and a preparation method therefor; also disclosed are applications of the crystal in preparing a medicament for treating tumor-related diseases.

Abstract: Examples described herein generally apply color transforms to visual content. A set of color transforms in a graphics pipeline that are requested by a plurality of applications can be determined. At least one of the set of color transforms or an ordering of the set of color transforms can be modified, based on one or more arbitration rules, to generate an arbitrated set of color transforms. The visual content can be generated for display based at least in part on applying the arbitrated set of color transforms in the graphics pipeline.

Abstract: The present invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and applications thereof in preparation of opiate receptor ? agonist related drugs; and in particular relates to the derivative compounds shown in formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.

Abstract: The present invention relates to a compound shown in formula (II) or a pharmaceutically acceptable salt thereof and an application of the same in preparing a drug for treating a disease related to angiotensin II receptor type 2 (AT2R).

Abstract: Examples described herein generally apply color transforms to visual content. A set of color transforms in a graphics pipeline that are requested by a plurality of applications can be determined. At least one of the set of color transforms or an ordering of the set of color transforms can be modified, based on one or more arbitration rules, to generate an arbitrated set of color transforms. The visual content can be generated for display based at least in part on applying the arbitrated set of color transforms in the graphics pipeline.

Abstract: The present invention relates to a series of 2,6-dioxaspiro [4,5] decane derivatives and applications thereof in preparation of opiate receptor p agonist related drugs; and in particular relates to the derivative compounds shown in formula (I), tautomers thereof or pharmaceutically acceptable compositions thereof.

Abstract: The present invention relates to a compound shown in formula (II) or a pharmaceutically acceptable salt thereof and an application of the same in preparing a drug for treating a disease related to angiotensin II receptor type 2 (AT2R).

Abstract: Disclosed in the present disclosure is a Dezocine analog, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Abstract: A request is sent from a new virtual function (VF) to a physical function for requesting the initialization of the new VF. The controlling physical function and the new VF establish a two-way communication channel that to start and end the VF's exclusive accesses to registers in a configuration space. The physical function uses a timing control to monitor that exclusive register access by the new VF is completed within a predetermined time period. The new VF is only granted a predetermined time period of exclusive access to complete its initialization process. If the exclusive access period is timed out, the controlling physical function can terminate the VF to prevent GPU stalls.

Abstract: Disclosed in the present disclosure is a Dezocine analogue, and particularly disclosed are compounds represented by formula (I), (II) and (III), a pharmaceutically acceptable salt or tautomer thereof.

Abstract: A request is sent from a new virtual function (VF) to a physical function for requesting the initialization of the new VF. The controlling physical function and the new VF establish a two-way communication channel that to start and end the VF's exclusive accesses to registers in a configuration space. The physical function uses a timing control to monitor that exclusive register access by the new VF is completed within a predetermined time period. The new VF is only granted a predetermined time period of exclusive access to complete its initialization process. If the exclusive access period is timed out, the controlling physical function can terminate the VF to prevent GPU stalls.